These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Anticoagulant treatment in myocardial infarct]. Bukowski Z. Wiad Lek; 1971 Mar 01; 24(5):433-7. PubMed ID: 4251758 [No Abstract] [Full Text] [Related]
3. [Long-term anticoagulant therapy]. Holzknecht F. Wien Med Wochenschr; 1972 Jun 03; 122(23):327-34. PubMed ID: 4625299 [No Abstract] [Full Text] [Related]
4. Anticoagulants updated--application in coronary artery disease. Robinson DS. Cardiovasc Clin; 1974 Jun 03; 6(2):9-22. PubMed ID: 4613466 [No Abstract] [Full Text] [Related]
5. [Analysis of the effectiveness of anticoagulant and fibrinolytic therapy in myocardial infarct]. Kheĭnonen IM, Makeeva GK, Kholodilina IM. Klin Med (Mosk); 1969 Jul 03; 47(7):41-8. PubMed ID: 5385087 [No Abstract] [Full Text] [Related]
6. [Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases]. Verstraete M. Clin Ter; 1975 Jun 15; 73(5):403-22. PubMed ID: 1139864 [No Abstract] [Full Text] [Related]
11. [Temporary connection between coronary thrombosis and myocardial infarct]. Emmrich P. Z Gesamte Inn Med; 1970 Jan 01; 25(1):10-7. PubMed ID: 5522124 [No Abstract] [Full Text] [Related]
12. [Principles of anticoagulant therapy in myocardial infarct]. Krug H. Pol Tyg Lek; 1972 Mar 27; 27(13):498-501. PubMed ID: 4553473 [No Abstract] [Full Text] [Related]
13. [Clinical use of heparin-heparinoid-mixtures]. Hörder MH, Stier WD, Brunswig D. Arzneimittelforschung; 1969 Nov 27; 19(11):1873-6. PubMed ID: 4190000 [No Abstract] [Full Text] [Related]
15. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins]. Delsart D, Chambefort V, Decousus H. Rev Prat; 2001 Sep 01; 51(13):1489-97. PubMed ID: 11601082 [No Abstract] [Full Text] [Related]
16. [Current views on anticoagulant and fibrinolytic treatment in coronary arterial disease]. Wojczuk J. Wiad Lek; 1971 Apr 15; 24(8):749-54. PubMed ID: 4252798 [No Abstract] [Full Text] [Related]
17. [State of the blood coagulation system under the experimental action of the anticoagulant bephedon hyperbaric oxygenation and their combination]. Reznikov KM, Trukhacheva LI, Ekimov VA. Probl Gematol Pereliv Krovi; 1981 Nov 15; 26(11):34-7. PubMed ID: 7323040 [No Abstract] [Full Text] [Related]
18. [Anticoagulant therapy in myocardial infarction. An evaluation of the present state]. Bjerkelund C. Nord Med; 1971 Jul 01; 85(26):789-99. PubMed ID: 4997493 [No Abstract] [Full Text] [Related]
19. [Advantages and hazards of drug treatment in surgery. Anticoagulants and fibrinolytic agents]. Gross R. Chirurg; 1968 May 01; 39(5):201-8. PubMed ID: 4974339 [No Abstract] [Full Text] [Related]
20. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis). Peters RJ, Spickler W, Théroux P, White H, Gibson M, Molhoek PG, Anderson HV, Weitz JI, Hirsh J, Weaver WD. Am Heart J; 2001 Aug 01; 142(2):237-43. PubMed ID: 11479461 [Abstract] [Full Text] [Related] Page: [Next] [New Search]